Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ghiglieri, Veronica ^a,b   Napolitano, Francesco ^c,d   Pelosi, Barbara ^e   Schepisi, Chiara ^b,f   Migliarini, Sara ^e   Di Maio, Anna ^c   Pendolino, Valentina ^b   Mancini, Maria ^b   Sciamanna, Giuseppe ^b,g   Vitucci, Daniela ^c,h   Maddaloni, Giacomo ^e   Giampà, Carmela ^b   Errico, Francesco ^c,d   Nisticò, Robert ^b,f   Pasqualetti, Massimo ^e,i   Picconi, Barbara ^b   Usiello, Alessandro ^c,j  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g UNIVERSITY OF ROME TOR VERGATA   (Italy)

^h UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

ⁱ ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^j SECOND UNIVERSITY OF NAPLES   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADENOSINE A2A RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; RASD2 PROTEIN, MOUSE;

ANIMAL; CORPUS STRIATUM; DRUG EFFECTS; FEMALE; GENE EXPRESSION; GENETICS; HIPPOCAMPUS; HUMAN; KNOCKOUT MOUSE; LONG TERM POTENTIATION; MALE; METABOLISM; MOTOR ACTIVITY; MOUSE; MUTATION; NERVE CELL PLASTICITY; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SPREADING CORTICAL DEPRESSION;

ANIMALS; CORPUS STRIATUM; CORTICAL SPREADING DEPRESSION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE; FEMALE; GABAERGIC NEURONS; GENE EXPRESSION; GTP-BINDING PROTEINS; HIPPOCAMPUS; HUMANS; LONG-TERM POTENTIATION; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTATION; NEURONAL PLASTICITY; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SEX FACTORS; SIGNAL TRANSDUCTION;

EID: 84937622598     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10933     Document Type: Article

References (53)

1. Usui, H. et al. Isolation of clones of rat striatum-specific mRNAs by directional tag PCR subtraction. J Neurosci 14, 4915-4926 (1994).
2. Errico, F. et al. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Mol Cell Neurosci 37, 335-345 (2008).
3. Vargiu, P. et al. The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors. Oncogene 23, 559-568 (2004).
4. Vargiu, P. et al. Thyroid hormone regulation of rhes, a novel Ras homolog gene expressed in the striatum. Brain Res Mol Brain Res 94, 1-8 (2001).
5. Falk, J. D. et al. Rhes: A striatal-specific Ras homolog related to Dexras1. J Neurosci Res 57, 782-788 (1999).
6. Vallortigara, J., Alfos, S., Micheau, J., Higueret, P. & Enderlin, V. T3 administration in adult hypothyroid mice modulates expression of proteins involved in striatal synaptic plasticity and improves motor behavior. Neurobiol Dis 31, 378-385 (2008).
7. Vallortigara, J., Chassande, O., Higueret, P. & Enderlin, V. Thyroid hormone receptor alpha plays an essential role in the normalisation of adult-onset hypothyroidism-related hypoexpression of synaptic plasticity target genes in striatum. J Neuroendocrinol 21, 49-56 (2009).
8. Harrison, L. M. & LaHoste, G. J. Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity. Neuroscience 137, 483-492 (2006).
9. Agretti, P. et al. Ras homolog enriched in striatum inhibits the functional activity of wild type thyrotropin, follicle-stimulating hormone, luteinizing hormone receptors and activating thyrotropin receptor mutations by altering their expression in COS-7 cells. J Endocrinol Invest 30, 279-284 (2007).
10. Harrison, L. M. & He, Y. Rhes and AGS1/Dexras1 affect signaling by dopamine D1 receptors through adenylyl cyclase. J Neurosci Res 89, 874-882 (2011).
11. Subramaniam, S. et al. Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9. J Biol Chem 285, 20428-20432 (2010).
12. Subramaniam, S., Sixt, K. M., Barrow, R. & Snyder, S. H. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324, 1327-1330 (2009).
13. Steffan, J. S. et al. SUMO modification of Huntingtin and Huntington's disease pathology. Science 304, 100-104 (2004).
14. Baiamonte, B. A., Lee, F. A., Brewer, S. T., Spano, D. & LaHoste, G. J. Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease. PLoS One 8, e53606 (2013).
15. Subramaniam, S. & Snyder, S. H. Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum). Neuropharmacology 60, 1187-1192 (2011).
16. Bang, S., Steenstra, C. & Kim, S. F. Striatum specific protein, Rhes regulates AKT pathway. Neurosci Lett 521, 142-147 (2012).
17. Harrison, L. M., Muller, S. H. & Spano, D. Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum. Neuroscience 236, 21-30 (2013).
18. Choi, B. R., Bang, S., Chen, Y., Cheah, J. H. & Kim, S. F. PKA modulates iron trafficking in the striatum via small GTPase, Rhes. Neuroscience 253, 214-220 (2013).
19. Wullschleger, S., Loewith, R. & Hall, M. N. TOR signaling in growth and metabolism. Cell 124, 471-484 (2006).
20. Santini, E., Valjent, E. & Fisone, G. mTORC1 signaling in Parkinson's disease and L-DOPA-induced dyskinesia: A sensitized matter. Cell Cycle 9, 2713-2718 (2010).
21. Subramaniam, S. et al. Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. Nat Neurosci 15, 191-193 (2012).
22. Ghiglieri, V. & Calabresi, P. Rhes, a key element of selective neuronal vulnerability in Huntington's disease: a striatal-specific license to kill during energy metabolism failure. Mov Disord 28, 735 (2013).
23. Picconi, B. & Calabresi, P. Rhes-mTORC1 interaction: a new possible therapeutic target in Parkinson's disease and L-dopainduced dyskinesia? Mov Disord 27, 815 (2012).
24. Quintero, G. C. & Spano, D. Exploration of sex differences in Rhes effects in dopamine mediated behaviors. Neuropsychiatr Dis Treat 7, 697-706 (2011).
25. Spano, D. et al. Rhes is involved in striatal function. Mol Cell Biol 24, 5788-5796 (2004).
26. Svenningsson, P. et al. DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44, 269-296 (2004).
27. Roche, K. W., O'Brien, R. J., Mammen, A. L., Bernhardt, J. & Huganir, R. L. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16, 1179-1188 (1996).
28. Hakansson, K. et al. Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. J Neurochem 96, 482-488 (2006).
29. Picconi, B. et al. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 6, 501-506 (2003).
30. Gerfen, C. R. et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432 (1990).
31. Calabresi, P. et al. Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and longterm potentiation, opposing forms of synaptic plasticity. J Neurosci 20, 8443-8451 (2000).
32. Chen, J. F. et al. The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc Natl Acad Sci USA 98, 1970-1975 (2001).
33. El Yacoubi, M., Ledent, C., Parmentier, M., Costentin, J. & Vaugeois, J. M. Adenosine A2A receptor knockout mice are partially protected against drug-induced catalepsy. Neuroreport 12, 983-986 (2001).
34. Lindskog, M. et al. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 418, 774-778 (2002).
35. Dhar, V., Nandi, A., Schildkraut, C. L. & Skoultchi, A. I. Erythroid-specific nuclease-hypersensitive sites flanking the human beta-globin domain. Mol Cell Biol 10, 4324-4333 (1990).
36. Pasqualetti, M. et al. A Hoxa2 knockin allele that expresses EGFP upon conditional Cre-mediated recombination. Genesis 32, 109-111 (2002).
37. Pham, C. T., MacIvor, D. M., Hug, B. A., Heusel, J. W. & Ley, T. J. Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci USA 93, 13090-13095 (1996).
38. Becker, J. B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 64, 803-812 (1999).
39. Castner, S. A. & Becker, J. B. Sex differences in the effect of amphetamine on immediate early gene expression in the rat dorsal striatum. Brain Res 712, 245-257 (1996).
40. Riccardi, P. et al. Sex differences in the relationship of regional dopamine release to affect and cognitive function in striatal and extrastriatal regions using positron emission tomography and [(1)(8)F]fallypride. Synapse 65, 99-102 (2011).
41. Shen, W., Flajolet, M., Greengard, P. & Surmeier, D. J. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 321, 848-851 (2008).
42. Calabresi, P. et al. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J Neurosci 17, 4536-4544 (1997).
43. Tuan, D., Solomon, W., Li, Q. & London, I. M. The "beta-like-globin" gene domain in human erythroid cells. Proc Natl Acad Sci USA 82, 6384-6388 (1985).
44. Johansson, I., Martensson, G., Nystrom, U., Nasic, S. & Andersson, R. Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients. BMC Infect Dis 13, 582 (2013).
45. Eddy, C. A. Experimental surgery of the genital system. In: Methods of animal experimentation, Gay WI, Heavner JEH, eds. Research surgery and care of the research animal. Orlando, FL: Academic Press 7, 191 (1986).
46. Riazi, K. et al. Sex and estrus cycle differences in the modulatory effects of morphine on seizure susceptibility in mice. Epilepsia 45, 1035-1042 (2004).
47. Pasqualetti, M. et al. Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain. Neuroscience 92, 601-611 (1999).
48. Migliarini, S., Pacini, G., Pelosi, B., Lunardi, G. & Pasqualetti, M. Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Mol Psychiatry 18, 1106-1118 (2013).
49. Napolitano, F. et al. Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. J Neurosci 30, 11043-11056 (2010).
50. Bagetta, V. et al. Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease. J Neurosci 32, 17921-17931 (2012).
51. Errico, F. et al. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPAinduced dyskinesia. Exp Neurol 232, 240-250 (2011).
52. Bagetta, V. et al. Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. J Neurosci 31, 12513-12522 (2011).
53. Nistico, R. et al. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis. PLoS One 8, e54666 (2013).